Biliary bile acid profiling reveals diagnostic signatures for cholangiocarcinoma and pancreatic ductal adenocarcinoma

Abstract The early diagnosis of biliopancreatic cancers, including cholangiocarcinoma (CCA) and pancreatic ductal adenocarcinoma (PDAC), remains challenging because currently available serum biomarkers have limited diagnostic accuracy. Bile acids are bioactive signaling molecules implicated in carcinogenesis and may reflect disease-specific alterations within the biliary microenvironment. We aimed to characterize biliary bile acid profiles in patients with PDAC and CCA and evaluate their diagnostic potential. Bile samples were prospectively collected from the common bile duct during endoscopic retrograde cholangiopancreatography (ERCP) in 71 individuals, including noncancer controls (CTRL, n = 41), patients with PDAC ( n = 14), and patients with CCA ( n = 16). Quantitative bile acid profiling was performed with ultra-performance liquid chromatography‒tandem mass spectrometry (UPLC‒MS‒MS/MS). Random forest, stability selection, least absolute shrinkage and selection operator, and elastic net algorithms were used as feature-selection methods to identify diagnostic bile acid signatures, which were evaluated using five-fold cross-validated receiver operating characteristic analysis. PDAC was associated with higher total and primary bile-acid concentrations than CCA, including higher cholic acid concentrations. Compared with controls, CCA was associated with lower total secondary bile-acid concentrations ( p = 0.009), including lower deoxycholic acid ( p = 0.013), lithocholic acid ( p = 0.021), and ursodeoxycholic acid ( p = 0.023) concentrations. After adjustment for bilirubin and alkaline phosphatase, glycocholic acid, taurochenodeoxycholic acid, and taurohyocholic acid were selected by all four feature-selection methods. Their combined model achieved a cross-validated area under the curve of 0.85 (95% CI, 0.79–0.90), compared with 0.67 (95% CI, 0.58–0.76) for CA19-9 and 0.61 (95% CI, 0.51–0.71) for CEA. A separate bile-acid model distinguished CCA from PDAC with an area under the curve of 0.87 (95% CI, 0.72–0.99), 85.7% sensitivity, and 87.5% specificity. CCA and PDAC patients exhibit distinct biliary bile acid profiles. Bile acid signatures identified after adjustment for cholestasis may complement conventional serum biomarkers during ERCP-based evaluation of indeterminate biliary strictures.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-15
DOI
https://doi.org/10.1038/s41598-026-80428-x
Primary Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Biliary bile acid profiling reveals diagnostic signatures for cholangiocarcinoma and pancreatic ductal adenocarcinoma

Riadh Sadik, Marcus Henricsson, Luca Natali, Peder R. Braadland et al.
Scientific Reports
Cholangiocarcinoma and Gallbladder Cancer Studies
article

Biliary bile acid profiling reveals diagnostic signatures for cholangiocarcinoma and pancreatic ductal adenocarcinoma

Riadh Sadik, Marcus Henricsson, Luca Natali, Peder R. Braadland, Maria Antonella Burza, Per Hedenström, Antonio Molinaro, Johannes R. Hov, Emil Larsson, Layana Darwich, Muhammad Arif
article en

Abstract

Abstract The early diagnosis of biliopancreatic cancers, including cholangiocarcinoma (CCA) and pancreatic ductal adenocarcinoma (PDAC), remains challenging because currently available serum biomarkers have limited diagnostic accuracy. Bile acids are bioactive signaling molecules implicated in carcinogenesis and may reflect disease-specific alterations within the biliary microenvironment. We aimed to characterize biliary bile acid profiles in patients with PDAC and CCA and evaluate their diagnostic potential. Bile samples were prospectively collected from the common bile duct during endoscopic retrograde cholangiopancreatography (ERCP) in 71 individuals, including noncancer controls (CTRL, n = 41), patients with PDAC ( n = 14), and patients with CCA ( n = 16). Quantitative bile acid profiling was performed with ultra-performance liquid chromatography‒tandem mass spectrometry (UPLC‒MS‒MS/MS). Random forest, stability selection, least absolute shrinkage and selection operator, and elastic net algorithms were used as feature-selection methods to identify diagnostic bile acid signatures, which were evaluated using five-fold cross-validated receiver operating characteristic analysis. PDAC was associated with higher total and primary bile-acid concentrations than CCA, including higher cholic acid concentrations. Compared with controls, CCA was associated with lower total secondary bile-acid concentrations ( p = 0.009), including lower deoxycholic acid ( p = 0.013), lithocholic acid ( p = 0.021), and ursodeoxycholic acid ( p = 0.023) concentrations. After adjustment for bilirubin and alkaline phosphatase, glycocholic acid, taurochenodeoxycholic acid, and taurohyocholic acid were selected by all four feature-selection methods. Their combined model achieved a cross-validated area under the curve of 0.85 (95% CI, 0.79–0.90), compared with 0.67 (95% CI, 0.58–0.76) for CA19-9 and 0.61 (95% CI, 0.51–0.71) for CEA. A separate bile-acid model distinguished CCA from PDAC with an area under the curve of 0.87 (95% CI, 0.72–0.99), 85.7% sensitivity, and 87.5% specificity. CCA and PDAC patients exhibit distinct biliary bile acid profiles. Bile acid signatures identified after adjustment for cholestasis may complement conventional serum biomarkers during ERCP-based evaluation of indeterminate biliary strictures.

Scientific ReportsVol. 16(1)
Oslo University Hospital (NO), University of Oslo (NO), Science for Life Laboratory (SE), Sahlgrenska University Hospital (SE), Region Västra Götaland (SE), Södra Älvsborg Hospital (SE), University of Gothenburg (SE)
Cholangiocarcinoma and Gallbladder Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon